Harbour Capital Advisors, LLC Pfizer Inc Transaction History

Harbour Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $189,342 - $243,226	4,824 New	4,824 $207,000
Q2 2020 Jul 21, 2020	SELL	$30.12 - $36.54 $185,539 - $225,086	-6,160 Closed	0 $0
Q1 2020 Apr 08, 2020	SELL	$27.03 - $38.62 $13,515 - $19,310	-500 Reduced 7.51%	6,160 $201,000
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $3,292 - $3,736	-100 Reduced 1.48%	6,660 $261,000
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $20,412 - $22,919	-552 Reduced 7.55%	6,760 $293,000
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $64,575 - $70,946	-1,722 Reduced 19.06%	7,312 $311,000
Q4 2018 Jan 23, 2019	SELL	$38.47 - $43.86 $37,623 - $42,895	-978 Reduced 9.77%	9,034 $394,000
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $15,683 - $19,023	-455 Reduced 4.35%	10,012 $441,000
Q1 2018 Apr 18, 2018	SELL	$31.91 - $37.02 $24,889 - $28,875	-780 Reduced 6.94%	10,467 $371,000
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $50,521 - $53,605	1,519 Added 15.61%	11,247 $407,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $301,568 - $332,211	9,728	9,728 $347,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.